Publicaciones científicas
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
Maria J Gonzalez-Rellan 1 , Tamara Parracho 2 , Violeta Heras 2 , Amaia Rodriguez 3 , Marcos F Fondevila 4 , Eva Novoa 4 , Natalia Lima 2 , Marta Varela-Rey 5 , Ana Senra 2 , Maria Dp Chantada-Vazquez 6 , Cristina Ameneiro 7 , Ganeko Bernardo 8 , David Fernandez-Ramos 8 , Fernando Lopitz-Otsoa 8 , Jon Bilbao 8 , Diana Guallar 7 , Miguel Fidalgo 2 , Susana Bravo 6 , Carlos Dieguez 4 , Maria L Martinez-Chantar 8 , Oscar Millet 9 , Jose M Mato 9 , Markus Schwaninger 10 , Vincent Prevot 11 , Javier Crespo 12 , Gema Frühbeck 3 , Paula Iruzubieta 12 , Ruben Nogueiras 13
Abstract
O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked N-acetylglucosamine moiety comes directly from the metabolism of glucose, lipids, and amino acids.
De addition and removal of O-GlcNAc of target proteins is mediated by two highly conserved enzymes: O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA), respectively. Deregulation of O-GlcNAcylation has been reported to be associated with various human diseases such as cancer, diabetes, and cardiovascular diseases.
The contribution of deregulated O-GlcNAcylation to the progression and pathogenesis of NAFLD remains intriguing, and a better understanding of its roles in this pathophysiological context is required to uncover novel avenues for therapeutic intervention.
By using a translational approach, our aim is to describe the role of OGT and O-GlcNAcylation in the pathogenesis of NAFLD. We used primary mouse hepatocytes, human hepatic cell lines and in vivo mouse models of steatohepatitis to manipulate O-GlcNAc transferase (OGT).
We also studied OGT and O-GlcNAcylation in liver samples from different cohorts of people with NAFLD. O-GlcNAcylation was upregulated in the liver of people and animal models with steatohepatitis. Downregulation of OGT in NAFLD-hepatocytes improved diet-induced liver injury in both in vivo and in vitro models.
Proteomics studies revealed that mitochondrial proteins were hyper-O-GlcNAcylated in the liver of mice with steatohepatitis. Inhibition of OGT is able to restore mitochondrial oxidation and decrease hepatic lipid content in in vitro and in vivo models of NAFLD.
These results demonstrate that deregulated hyper-O-GlcNAcylation favors NAFLD progression by reducing mitochondrial oxidation and promoting hepatic lipid accumulation.
CITA DEL ARTÍCULO Mol Metab. 2023 Jul 13;101776. doi: 10.1016/j.molmet.2023.101776
Nuestros autores
